At Neubio, we have always been driven by a mission to create a positive impact in the medical field. With our cochlear implant device manufactured in India, we are changing the landscape of social impact, enabling NGOs and CSR partners to maximize the value of every dollar raised and spent. In this blog post, we will explore our unique model for good and how it empowers organizations to make a greater difference by passing on direct costs at the manufacturing level.
Empowering NGOs and CSR Partners
There are several widely recognized India-based CSR and charities that support cochlear implant programs in India that have been widely recognized. The India CSR network is dedicated to alleviating hearing loss and helping patients through programs nationwide. Let's take a closer look at their remarkable work:
Hans Foundation: Launched in December 2013, the Hans Foundation was specifically developed to cater to impoverished families for whom the cost of a cochlear implant is nearly impossible. The Hans Foundation has conducted over 800 cochlear implants and hearing aids.
I Hear Foundation: The I Hear Foundation has been tremendously successful in offering cochlear implants for the past 20 years, with over 2000 success stories. The organization's helps raise donations to assist those who can not afford medical expenses.
Charity - I Can Hear Foundation: The Charity - I Can Hear Foundation is another reputable organization that has gained popularity mainly for its consistent efforts in raising awareness about cochlear implant device in India, childhood hearing loss, early diagnostic support, and more. This Non-Profit Organization has partnered with Adventis ENT Services and SpHear Speech & Hearing Clinics.
Challenges Encountered by Indian NGOs and CRS in Conducting Cochlear Implant Surgery
NGOs, government agencies, and CSR partners have traditionally purchased medical devices at retail prices or MSRP, which significantly restricts their available resources for crucial expenses like hospital fees, post-care services, and therapy fees. Moreover, the involvement of intermediaries in price negotiations often leads to inflated costs and potential profit margins for middlemen. Imported medical devices tend to carry inherent costs stemming from higher manufacturing expenses in developed countries, in addition to additional fees related to imports and licensing for shipping and distribution. In contrast, our Make in India manufacturing model empowers these impact partners with greater flexibility and cost-effectiveness.
As you can imagine, the funds required to support cochlear implant programs can add up. Hence, these programs are typically run by well-funded organizations and influential charities with substantial financial capabilities, which does not necessarily determine the quality or effectiveness of their impact. It can be argued that smaller and more agile groups have a better pulse on local needs and can provide the personalized support required by cochlear implant candidates.
There is also a shift in the fundraising landscape as corporate sponsors increasingly prioritize projects that offer more affordable options and demonstrate immediate and measurable results on impact reports. This has led to challenges for certain charities in securing funding to cover the higher costs associated with these types of programs – making it more challenging for certain impact groups to receive funding to cover the higher costs associated with these types of programs.
Here is a video of our impact this year:
Direct from Manufacturing
The challenges faced regarding the process of the cochlear implant by NGO India is to underscore the importance of exploring alternative approaches to procurement and partnerships. While cochlear implant projects may initially be more complex and costly, the long-term benefits of providing children with hearing abilities for their education and integration into society are invaluable. Our direct manufacturing model enables organizations to bridge the gap between funding challenges and the essential needs of their constituents.
By procuring devices directly from the manufacturer, organizations gain flexibility and efficiency, allowing them to establish stronger relationships with their donor partners and maximize their impact. With our aim to provide at least a 30-40% savings for qualified impact partners, these organizations can expand their focus beyond the devices themselves and provide comprehensive care and support to the patients. By eliminating unnecessary intermediaries and offering direct manufacturing pricing, we ensure that the primary focus remains on the well-being and overall care of the patients.
Our impact partners can showcase how each donated dollar goes further, reaching and supporting a larger number of individuals in need. This empowers them to allocate more resources towards post-care and other critical aspects of the patient's journey. By demonstrating the tangible results of their work, they can make a compelling case for continued support with their donor partners, fostering lasting positive change in the lives of those they serve.
Conclusion:
We believe that our 'direct from manufacturing' model is poised to revolutionize the medical space, paving the way for greater impact and transformation. With our ability to eliminate fixed costs associated with imported devices and minimizing intermediaries to offer our cochlear implant devices at manufacturing costs, we can empower more NGOs and CSR partners to maximize their impact. This approach not only enables them to acquire devices at significantly lower prices but also grants them the flexibility to allocate resources towards the cochlear machine and comprehensive care and support for underprivileged patients. With this model, our goal is to drive profound social impact, transforming lives, and fostering a healthier, more inclusive society.